Items where Author is "<span class="person_name">Murnane, D.</span>"
Number of items: 8.
Article
  • Characterization of latent heat-releasing phase change materials for dermal therapies. (2011) D.G. Wood, Marc Brown, S. A. Jones and D. Murnane
  • Formation and measurement of process induced disorder during the manufacture of inhalation medicines. (2011) P.G. Royall, B. Woodhead, S.J. Tang, G.P. Martin, B.M. Stockton and D. Murnane
    • Other
  • Particle aggregation of salmeterol xinafoate (SX) in HFA134a high pressure suspensions. (2006) D. Murnane, G.P. Martin and C. Marriott
  • Evidence for flocculation-controlled microcrystallisation of salmeterol xinafoate. (2006) D. Murnane, G.P. Martin, I. Haley and C. Marriott
  • Investigation of a reverse-phase high performance liquid chromatography (RP-HPLC) method for a weakly basic drug. (2005) D. Murnane, G. P. Martin and C. Marriott
  • Transiently supersaturated solutions from the dissolution of amorphous powders for topical drug delivery. (2010) I. A. Palmer, S. A. Jones, D. Murnane, M.J. Traynor, Gary Moss and Marc Brown
  • The effect of aerodynamic particle size and solid state disorder on salmeterol xinafoate deposition from pressurised metered dose and dry powder inhaler formulations. (2013) S. Jaffari, G. Sandhu, G. P. Martin, B. Forbes, E. Collins and D. Murnane
  • Assessment of a cyclone-type spacer device for use in dry powder inhalation. (2013) I. Parisini, S. J. Cheng, D. D. Symons, Marc Brown, A. Kostrzewski and D. Murnane